New topline Olinvyk data highlighting reduced cost per admission from ARTEMIS real-world outcomes study – Trevena Inc

Trevena, Inc. announced new topline Olinvyk data from the ARTEMIS study. The ARTEMIS study was an electronic medical records (EMR) based assessment focused on clinical and health resource utilization outcomes at Cleveland Clinic and Wake Forest Baptist Health. The study reviewed Olinvyk-treated patients in the ~200 patient VOLITION study with comparable surgical patients (matched patients) treated with other IV opioids, […]